Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Zonisamide for bipolar depression.

Michael S Wilson¹, Robert L Findling

¹Case Western Reserve University/University Hospitals Case Medical Center, Division of Child & Adolescent Psychiatry, Department of Psychiatry, 11100 Euclid Ave, Cleveland, OH 44106-5080, USA.

Expert Opinion on Pharmacotherapy

|December 14, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Pragmatic SMART Study of Medication and CBT Sequencing in Pediatric Anxiety Disorders: A Randomized Clinical Trial.

The American journal of psychiatry·2026

Same author

Identifying the Aggression Impulsive/Reactive (AIR) Profile in Youth With Behavioral Challenges.

JAACAP open·2026

Same author

Diagnosis and Medication Treatment of Schizophrenia in Adolescents.

Drugs·2026

Same author

Data Diversity vs. Model Complexity in the Prediction of Pediatric Bipolar Disorder: Evidence from Academic and Community Clinical Samples.

medRxiv : the preprint server for health sciences·2026

Same author

Latent profiles of mood: Toward an empirical definition of mixed mood in youth.

Journal of affective disorders·2026

Same author

Editors' Best of 2025.

JAACAP open·2026

Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026

Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026

Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026

Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026

Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026

Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026

See all related articles

Zonisamide showed modest effectiveness for bipolar depression with a low risk of mania. However, side effects led to a high dropout rate, making it not a recommended first-line treatment.

Area of Science:

Psychiatry
Pharmacology

Background:

Bipolar depression research is expanding, focusing on novel treatments.
Key research goals include efficacy, tolerability, and preventing mood switching.

Purpose of the Study:

To evaluate zonisamide's effectiveness and tolerability in treating bipolar depression.
To assess the risk of manic or hypomanic switching with zonisamide use.

Main Methods:

An open-label pilot study was conducted.
Effectiveness, tolerability, and mood switching were monitored.

Main Results:

Zonisamide demonstrated a very low rate of switching to mania.
Modest effectiveness was observed, but a high dropout rate occurred due to side effects.

Related Experiment Videos

Conclusions:

Zonisamide presents a low risk for inducing mania in bipolar depression patients.
Due to tolerability issues and high dropout rates, zonisamide is not advised as a primary treatment.
Further research is needed to clarify zonisamide's role in bipolar depression management.